SCHEMBL29407686

SCHEMBL29407686

Cn1c(C2CCNC2)c(-c2ccc(Oc3ncccn3)cc2)c2c(N)ncnc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 13/20 0.49
▸ SRC P12931 7/20 0.49
▸ TEK Q02763 12/20 0.46
▸ KDR P35968 11/20 0.44
▸ EGFR P00533 4/20 0.43
▸ ABL1 P00519 2/20 0.43
▸ ABL2 P42684 2/20 0.43
▸ HCK P08631 1/20 0.40
▸ BTK Q06187 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ RGS12 O14924 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ GMNN O75496 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ LYN P07948 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22659188 1.00 LCK (0.49) LCKSRCTEKKDREGFR
SCHEMBL26587238 0.94 LCK (0.49) LCKSRCTEKKDREGFR
SCHEMBL26109125 0.86 LCK (0.44) LCKSRCTEKKDREGFR
SCHEMBL30582591 0.84 LCK (0.42) LCKSRCTEKKDREGFR
SCHEMBL26108281 0.84 LCK (0.42) LCKSRCTEKKDREGFR
SCHEMBL30303782 0.80 LCK (0.47) LCKSRCTEKKDRHCK
SCHEMBL28693886 0.80 LCK (0.47) LCKTEKKDREGFRBTK
SCHEMBL22676631 0.78 BTK (0.53) LCKSRCKDREGFRABL1
SCHEMBL31219400 0.78 LCK (0.42) LCKSRCTEKKDREGFR
SCHEMBL22676199 0.77 BTK (0.53) LCKSRCKDREGFRABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874707-A FGFR inhibitors and methods of use thereof 传达治疗有限公司 2025-04-25 — — CN disclosed
CN-114126620-B FGFR inhibitors and methods of use thereof 传达治疗有限公司 2024-12-31 — — CN disclosed
EP-3968999-A1 FGFR INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2022-03-23 — — EP disclosed
CN-114126620-A FGFR inhibitors and methods of use thereof 传达治疗有限公司 2022-03-01 — — CN disclosed
Send feedback